Addressing the Challenges of Cold Agglutinin Disease: From Diagnosis to Treatment
2-Year Results From the CARDINAL Study: Sutimlimab for Complement C1s Inhibition in Cold Agglutinin Disease
Login to view comments.
Click here to Login